Balance Sheet for GW Pharmaceuticals Plc (GWPRF)

$ 12.53 0.00 (0.00%) Volume: 2.99k 3:04 PM EDT Aug 16, 2019
Statement: View:
Assets [+] in Thousands of Dollars
12/2018 09/2018 09/2017 09/2016 09/2015
Cash and Equivalents 591,497 354,913 322,154 487,833 355,926
Restrictable Cash - - - - -
Marketable Securities - - - - -
Accounts Receivable 4,192 2,122 1,367 1,014 565
Loans Receivable - - - - -
Other Receivables - - 3,635 1,487 1,449
Receivables 4,192 2,122 1,367 30,283 21,170
Inventories, Raw Materials 676 506 267 328 480
Inventories, Work in Progress 28,709 17,529 4,513 4,203 5,586
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 3,645 1,026 889 1,003 1,141
Inventories, Other 33,030 19,061 5,669 5,535 7,207
Inventories, Adjustments & Allowances - - - - -
Inventories 33,030 19,061 5,669 5,535 7,207
Prepaid Expenses 17,903 14,615 35,392 3,436 2,340
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 646,622 390,711 364,582 527,087 386,643
Land and Improvements - - - - -
Buildings and Improvement 36,004 36,091 40,890 18,117 12,372
Machinery, Furniture and Equipment 35,079 35,412 30,539 18,563 17,066
Construction in Progress 44,546 34,165 12,319 27,829 26,191
Fixed Assets, Other 4,573 4,694 (15) - -
Fixed Assets, Total 120,202 110,362 83,733 64,509 55,629
Gross Fixed Assets 120,202 110,362 83,733 64,509 55,629
Accumulated Depreciation (29,370) (27,981) (20,558) (13,761) (12,087)
Net Fixed Assets 90,832 82,381 63,175 50,748 43,542
Intangibles 5,548 7,812 1,405 820 371
Cost in Excess 6,959 6,959 6,959 6,789 7,895
Non-Current Deferred Income Taxes 8,720 7,334 6,805 5,047 633
Other Non-Current Assets 2,935 3,150 1,401 - -
Total Non-Current Assets 109,446 99,824 78,340 63,403 52,442
Total Assets 756,068 490,535 442,922 590,489 439,085
Liabilities [+] in Thousands of Dollars
12/2018 09/2018 09/2017 09/2016 09/2015
Accounts Payable 9,796 9,741 7,757 5,574 22,514
Short Term Debt 575 857 275 275 168
Notes Payable - - - - -
Accrued Expenses 33,995 31,161 26,907 33,099 12,690
Accrued Liabilities 33,995 31,161 26,907 33,099 12,690
Deferred Revenues 2,208 3,405 3,091 3,500 4,954
Current Deferred Income Taxes (1,265) (317) (27,754) (2,343) (18,940)
Other Current Liabilities 17,104 10,968 6,880 3,092 1,753
Total Current Liabilities 66,216 58,669 44,909 45,540 42,080
Long Term Debt 1,454 1,535 1,741 6,462 2,334
Deferred Income Tax 4,016 6,427 5,707 6,978 10,191
Other Non-Current Liabilities 14,318 15,172 15,449 19,256 10,191
Minority Interest - - - - -
Capital Lease Obligations 1,454 1,535 1,741 6,462 2,334
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 15,772 16,707 17,190 25,717 25,322
Total Liabilities 81,988 75,376 62,099 71,257 67,402
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 674,080 415,159 380,823 519,232 371,683
Common Par 564 530 482 394 396
Additional Paid in Capital 1,581,144 1,246,857 916,726 725,089 529,293
Cumulative Translation Adjustments - - - - -
Retained Earnings (828,940) (757,034) (461,867) (231,708) (187,084)
Treasury Stock - - - - -
Other Equity Adjustments (78,688) (75,194) (74,518) 25,458 29,079
Total Capitalization 674,080 415,159 380,823 519,232 384,481
Total Equity 674,080 415,159 380,823 519,232 371,683
Total Liabilities & Shareholder's Equity 756,068 490,535 442,922 590,489 439,085
Cash Flow (303,623) (303,131) (173,538) (87,264) (66,789)
Working Capital 580,406 332,042 319,673 481,547 344,564
Free Cash Flow (93,210) (265,272) (170,058) (122,201) (97,744)
Invested Capital 674,080 415,159 380,823 519,232 371,683
Shares Outstanding - Common Class Only 366,617 340,247 304,440 302,093 261,180
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 366,617 340,247 304,440 302,093 261,180
Total Common Shares Outstanding 366,617 340,247 304,440 302,093 261,180
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 366,458 333,936 303,600 270,400 246,400
Diluted Weighted Shares Outstanding 366,458 333,936 304,100 270,400 246,400